BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schild K, Knobloch J, Yakin Y, Jungck D, Urban K, Müller K, Koch A. IL-5 release of CD4+ non-effector lymphocytes is increased in COPD — modulating effects of moxifloxacin and dexamethasone. International Immunopharmacology 2011;11:444-8. [DOI: 10.1016/j.intimp.2010.12.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Meghraoui-kheddar A, Pierre A, Sellami M, Audonnet S, Lemaire F, Le Naour R. Elastin receptor (S-gal) occupancy by elastin peptides modulates T-cell response during murine emphysema. American Journal of Physiology-Lung Cellular and Molecular Physiology 2017;313:L534-47. [DOI: 10.1152/ajplung.00465.2016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
2 Pierre A, Lemaire F, Meghraoui-Kheddar A, Audonnet S, Héry-Huynh S, Le Naour R. Impact of aging on inflammatory and immune responses during elastin peptide-induced murine emphysema. Am J Physiol Lung Cell Mol Physiol 2019;316:L608-20. [PMID: 30675803 DOI: 10.1152/ajplung.00402.2018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
3 Baker KE, Bonvini SJ, Donovan C, Foong RE, Han B, Jha A, Shaifta Y, Smit M, Johnson JR, Moir LM. Novel drug targets for asthma and COPD: lessons learned from in vitro and in vivo models. Pulm Pharmacol Ther 2014;29:181-98. [PMID: 24929072 DOI: 10.1016/j.pupt.2014.05.008] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
4 Knobloch J, Yakin Y, Körber S, Grensemann B, Bendella Z, Boyaci N, Gallert WJ, Yanik SD, Jungck D, Koch A. Simvastatin requires activation in accessory cells to modulate T-cell responses in asthma and COPD. Eur J Pharmacol 2016;788:294-305. [PMID: 27343379 DOI: 10.1016/j.ejphar.2016.06.037] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
5 Mat Z, Grensemann B, Yakin Y, Knobloch J, Koch A. Effect of lipoteichoic acid on IL-2 and IL-5 release from T lymphocytes in asthma and COPD. Int Immunopharmacol 2012;13:284-91. [PMID: 22542695 DOI: 10.1016/j.intimp.2012.04.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
6 Assar S, Nosratabadi R, Khorramdel Azad H, Masoumi J, Mohamadi M, Hassanshahi G. A Review of Immunomodulatory Effects of Fluoroquinolones. Immunol Invest 2020;:1-20. [PMID: 32746743 DOI: 10.1080/08820139.2020.1797778] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Shang J, Zhao J, Wu X, Xu Y, Xie J, Zhao J. Interleukin-33 promotes inflammatory cytokine production in chronic airway inflammation. Biochem Cell Biol 2015;93:359-66. [PMID: 26158865 DOI: 10.1139/bcb-2014-0163] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]